Preclinical Research

The Solution to Shorter SEND Timelines


Are you currently experiencing challenges with SEND, specifically when it comes to timelines? You can rely on Altasciences to ask the right questions from the get-go, to smoothly guide you through the SEND process and help you avoid potential delays in the preparation of reliable SEND datasets for your regulatory submissions.

Contact our SEND team today to experience the difference. Contact SEND Expert

Microsampling Benefits


As an alternative to traditional venipuncture, blood microsampling represents a less invasive and simplified collection technique, resulting in numerous benefits for preclinical and clinical studies alike. Recent advances in device technology, specifically the Mitra® VAMS® microsampler manufactured by Neoteryx, has enabled Altasciences to fully support blood microsampling programs. With over 12 Mitra® VAMS® assays validated for a range of drug applications and study types, we look forward to sharing our combined expertise in support of your next microsampling program.

The Right Strategy for your Small Molecule Program

Did you know that, in addition to large molecule work, Altasciences' preclinical team has extensive experience in designing and conducting safety assessment programs for small molecules? Our solutions meet all regulatory requirements, and include IND/NDA-enabling toxicology, safety pharmacology, and laboratory services in both rodent and non-rodent species.

Choose Altasciences for your small molecule safety assessment program and let us guide you seamlessly through each milestone.

Up Close and Personal with Francis Douville

.custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

Francis Douville joined the Altasciences team in 2018, as Senior Vice President, Technical Operations, for our preclinical services.

Our Animal Welfare Program Built with Love


It's animal welfare month at Altasciences! Through the course of your regulatory required preclinical research, Altasciences considers the humane and appropriate care of all animals a high priority. Our team is dedicated to animal welfare and environmental enrichment, and understands the importance of compassion, sensitivity, and adherence to regulatory guidelines.
Learn more on our animal welfare and C.A.R.E. programs	Discover our preclinical solutions
Speak with our experts, or better yet, come for a visit.

Answers to your questions on the development of biologics and biosimilars

Renowned for our full-service offering, we often get asked — how does Altasciences manage the development process for biologics and biosimilars so seamlessly from the required preclinical studies to first-in-human trials?

When and How to Use Thromboelastography (TEG) in Preclinical Studies

Thromboelastography (TEG) is often used to measure clot strength, diagnose and quantify fibrinolysis, as well as help diagnose platelet dysfunction and hypercoagulability. TEG analysis is utilized in preclinical studies targeting bleeding disorders and platelet dysfunction, and can add valuable information in drug development focused on hematology and coagulation.

Want to know more? Our scientific poster discusses the various benefits, challenges, and methods associated with the use of TEG in preclinical studies, including a case study.

View the Poster and Case Study

Learn more on Altasciences' Preclinical Studies